Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

Evaluating trifluridine + tipiracil hydrochloride in a fixed combination (TAS-102) for the treatment of colorectal cancer.

Mulet N, Matos I, Noguerido A, Martini G, Élez ME, Argilés G, Tabernero J.

Expert Opin Pharmacother. 2018 Apr;19(6):623-629. doi: 10.1080/14656566.2018.1453497. Epub 2018 Mar 28.

PMID:
29537896
2.

Analysis of Fusobacterium persistence and antibiotic response in colorectal cancer.

Bullman S, Pedamallu CS, Sicinska E, Clancy TE, Zhang X, Cai D, Neuberg D, Huang K, Guevara F, Nelson T, Chipashvili O, Hagan T, Walker M, Ramachandran A, Diosdado B, Serna G, Mulet N, Landolfi S, Ramon Y Cajal S, Fasani R, Aguirre AJ, Ng K, Élez E, Ogino S, Tabernero J, Fuchs CS, Hahn WC, Nuciforo P, Meyerson M.

Science. 2017 Dec 15;358(6369):1443-1448. doi: 10.1126/science.aal5240. Epub 2017 Nov 23.

PMID:
29170280
3.

Bacterial membrane injuries induced by lactacin F and nisin.

Dalmau M, Maier E, Mulet N, Viñas M, Benz R.

Int Microbiol. 2002 Jun;5(2):73-80.

4.

Partial characterization of a novel oestrogen-induced protein in the rat adenohypophysis.

Casabiell X, Zugaza JL, Pombo CM, Bokser L, Mulet N, Casanueva FF.

J Mol Endocrinol. 1993 Jun;10(3):345-57.

PMID:
8373518

Supplemental Content

Support Center